Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2021
Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study
Andreas K Øvlisen, Lasse H Jakobsen, Sandra Eloranta, et al.
International Journal of Cancer
|
December 26, 2025
Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases
Klaus Rostgaard, Stephen Hamilton-Dutoit, Kristina L Lauridsen, et al.
International Journal of Molecular Sciences
|
March 28, 2024
The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa
Stine Dahl Vest, Patrick Rene Gerhard Eriksen, Fleur A de Groot, et al.
European Journal of Haematology
|
November 6, 2024
Risk of Cardiovascular Disease in Patients With Classical Hodgkin Lymphoma: A Danish Nationwide Register-Based Cohort Study
Sissel J Godtfredsen, Harman Yonis, Joachim Baech, et al.
JCO Clinical Cancer Informatics
|
April 12, 2024
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma
Rasmus Rask Kragh Jørgensen, Fanny Bergström, Sandra Eloranta, et al.
The Lancet. Oncology
|
July 13, 2025
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial
Justin Ferdinandus, Gundolf Schneider, Alden Moccia, et al.
The Lancet. Haematology
|
October 4, 2016
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study
Claudio Agostinelli, Andrea Gallamini, Luisa Stracqualursi, et al.
Lancet (London, England)
|
July 6, 2024
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
Peter Borchmann, Justin Ferdinandus, Gundolf Schneider, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2021
Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study
Andreas K Øvlisen, Lasse H Jakobsen, Sandra Eloranta, et al.
International Journal of Cancer
|
December 26, 2025
Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases
Klaus Rostgaard, Stephen Hamilton-Dutoit, Kristina L Lauridsen, et al.
International Journal of Molecular Sciences
|
March 28, 2024
The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa
Stine Dahl Vest, Patrick Rene Gerhard Eriksen, Fleur A de Groot, et al.
European Journal of Haematology
|
November 6, 2024
Risk of Cardiovascular Disease in Patients With Classical Hodgkin Lymphoma: A Danish Nationwide Register-Based Cohort Study
Sissel J Godtfredsen, Harman Yonis, Joachim Baech, et al.
JCO Clinical Cancer Informatics
|
April 12, 2024
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma
Rasmus Rask Kragh Jørgensen, Fanny Bergström, Sandra Eloranta, et al.
The Lancet. Oncology
|
July 13, 2025
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial
Justin Ferdinandus, Gundolf Schneider, Alden Moccia, et al.
The Lancet. Haematology
|
October 4, 2016
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study
Claudio Agostinelli, Andrea Gallamini, Luisa Stracqualursi, et al.
Lancet (London, England)
|
July 6, 2024
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
Peter Borchmann, Justin Ferdinandus, Gundolf Schneider, et al.
Page
of 4